Atenolol Market Size

Atenolol Market size was valued at USD 11.59 Billion in 2023 and is expected to reach USD 22.97 Billion by the end of 2036, expanding at around 5.4% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of atenolol is assessed at USD 12.15 Billion. The growth of the market can be attributed to the worldwide expanding ratio of hypertension among people, coupled with the surging awareness regarding the concerned complexities of hypertension.  As per the World Health Organization (WHO) data, an estimated 1.28 billion persons aged 30-79 years have hypertension across the globe, with the majority two-thirds residing in low- and middle-income nations. Further, the dynamically growing demand for antihypertensive drugs throughout the world is also projected to skyrocket the growth of the global atenolol market over the forecast period.

In addition to these, factors that are believed to fuel the market growth of atenolol include the significant rise in the aged population throughout the world, as aged people are more prone to have disorders comprising hypertension, cardiac diseases, diabetes, and so on. As stated by the World Health Organization, the global population of persons aged 60 and above is projected to surge from 1 billion in 2020 to 1.4 billion by 2030. Moreover, the global population of people aged 60 and above is expected to augment to 2.1 billion by 2050. Further, poor lifestyle along with poor dietary habits among people is also estimated to fuel the market growth in the coming years.